Vbi Vaccines Stock In The News

VBIV Stock  USD 0.60  0.02  3.45%   
The tone or emotional content of news articles related to VBI Vaccines can affect its prices. Positive news sentiment can lead to an increase in demand for VBI Vaccines' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of VBI Vaccines' news coverage and content from conventional and social sources shows investors' bearish mood towards VBI Vaccines. The specific impact of VBI Vaccines news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of VBI Vaccines' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using VBI Vaccines headlines in addition to utilizing other, more conventional financial analysis modules. Check out VBI Vaccines Backtesting and VBI Vaccines Hype Analysis.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.

VBI Vaccines Today Top News and Investor Outlook

Yahoo News
VBI Vaccines Presents Additional Biomark...
https://finance.yahoo.com/news/vbi-vaccines-presents-additional-biomarker-130000456.html
 Bullish
Yahoo News
VBI Vaccines Reports Third Quarter 2023 Financial Results
https://finance.yahoo.com/news/vbi-vaccines-reports-third-quarter-210500068.html
 Neutral
Yahoo News
VBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine Program
https://finance.yahoo.com/news/vbi-vaccines-expands-proprietary-technology-120000626.html
 Bullish
Yahoo News
VBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901, Induced Broad and Durable Protective Titers Against Variants of Concern
https://finance.yahoo.com/news/vbi-vaccines-pan-coronavirus-vaccine-113000954.html
 Bullish
Yahoo News
VBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901 in Recurrent GBM
https://finance.yahoo.com/news/vbi-vaccines-announces-dosing-first-120000303.html
 Bullish
Yahoo News
VBI Vaccines Partner Brii Biosciences An...
https://finance.yahoo.com/news/vbi-vaccines-partner-brii-biosciences-120000803.html
 Bullish
Yahoo News
VBI Vaccines Reports Second Quarter 2023 Financial Results
https://finance.yahoo.com/news/vbi-vaccines-reports-second-quarter-120000724.html
 Neutral
Yahoo News
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates
https://finance.yahoo.com/news/puma-biotech-pbyi-surpasses-q2-222513734.html
 Bullish
Yahoo News
VBI Vaccines Announces Closing of Underwriters’ Partial Exercise of Option to Purchase Additional Common Shares
https://finance.yahoo.com/news/vbi-vaccines-announces-closing-underwriters-120000168.html
 Bullish
Yahoo News
VBI Vaccines Announces PreHevbri® is Now Available in the Netherlands and Belgium for the Prevention of Hepatitis B in Adults
https://finance.yahoo.com/news/vbi-vaccines-announces-prehevbri-now-120000593.html
 Bullish

VBI Vaccines Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide VBI and other traded companies coverage. We help investors stay connected with VBI headlines for the 29th of March to make an informed investment decision based on correlating the impacts of news items on VBI Stock performance. Please note that trading solely based on the VBI Vaccines hype is not for everyone as timely availability and quick action are needed to avoid losses.
VBI Vaccines' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help VBI Vaccines investors visualize upcoming and past events in order to time the market based on VBI Vaccines noise-free hype analysis.
VBI Vaccines stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the VBI earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about VBI Vaccines that are available to investors today. That information is available publicly through VBI media outlets and privately through word of mouth or via VBI internal channels. However, regardless of the origin, that massive amount of VBI data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of VBI Vaccines news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of VBI Vaccines relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to VBI Vaccines' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive VBI Vaccines alpha.

VBI Largest EPS Surprises

Earnings surprises can significantly impact VBI Vaccines' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-03-13
2022-12-31-0.07-0.08-0.0114 
2022-11-10
2022-09-30-0.08-0.09-0.0112 
2021-11-08
2021-09-30-0.07-0.060.0114 
2021-08-02
2021-06-30-0.06-0.07-0.0116 
2021-05-10
2021-03-31-0.06-0.07-0.0116 
2020-05-06
2020-03-31-0.06-0.050.0116 
View All Earnings Estimates

VBI Vaccines Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to VBI Vaccines Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
5th of March 2024
VBI Vaccines Inc at H C Wainwright Hepatitis B Virus Virtual Conference Transcript
at gurufocus.com 
news
16th of February 2024
VBI Vaccines Inc. Short Interest Update
at thelincolnianonline.com 
seekingalpha News
14th of February 2024
VBI signs deal to sell manufacturing capabilities, certain assets with Brii Biosciences
at seekingalpha.com 
Google News at Macroaxis
7th of February 2024
VBI Vaccines Secures Forbearance Agreement Extensions - TipRanks.com - TipRanks
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VBI Vaccines in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VBI Vaccines' short interest history, or implied volatility extrapolated from VBI Vaccines options trading.
When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:
Check out VBI Vaccines Backtesting and VBI Vaccines Hype Analysis.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for VBI Stock analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.79)
Revenue Per Share
0.689
Quarterly Revenue Growth
19.896
Return On Assets
(0.29)
Return On Equity
(2.20)
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.